They’re literally resurrecting the Spanish flu virus through reverse genetics, and it has 80% lethality in mice.
STORY AT-A-GLANCE
- Less than two months ago, scientists funded by the National Institutes of Health (NIH) and Dr. Anthony Fauci’s National Institute of Allergy and Infectious Diseases (NIAID) announced they’d resurrected the Spanish flu virus through reverse genetics
- Now, scientists at Boston University report they’ve engineered an Omicron strain of SARS-CoV-2 with an 80% lethality in mice. The new hybrid was created by extracting spike protein from the Omicron BA.1 variant of SARS-CoV-2 and attaching it to the original Wuhan Alpha strain
- The research was funded by four grants from the NIH/NIAID, but because those funds were supposedly “earmarked” primarily for equipment, they did not clear the viral engineering portion of the experiment with the NIH. The NIH is reviewing the case to determine whether the University violated rules for enhanced potential pandemic pathogen (ePPP) research
- Boston University denies the research qualifies as “gain of function” research as the Alpha strain’s lethality was reduced from 100% to 80%. However, the Alpha strain did gain function, namely immune escape, which it didn’t have before. The immune-evading properties came from the Omicron spike
- The likelihood of SARS-CoV-2 assembling itself into a Wuhan Alpha strain with Omicron spike protein “in the wild” is just about nil, as the Wuhan strain has mutated out of existence already. Were it not for these madmen, we would never have had to worry about this kind of recombination
Less than two months ago, we reported scientists funded by the National Institutes of Health (NIH) and Dr. Anthony Fauci’s National Institute of Allergy and Infectious Diseases (NIAID) have resurrected the Spanish flu virus through reverse genetics.
Keep reading with a private membership…
Subscribe to keep reading this article and access all article archives. See membership options.
Already a paid subscriber? Sign in.
